Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ExaWizards Inc. ( (JP:4259) ) has shared an announcement.
ExaWizards Inc.’s subsidiary, ExaMD Inc., has obtained crucial licenses for manufacturing and marketing Type II medical devices, as well as a sales license from the Tokyo Metropolitan Government. This development allows ExaMD to independently manage the development, manufacturing, and sales of their AI-driven medical devices, particularly those aimed at diagnosing dementia through conversational analysis. The company is analyzing the potential impact on its future business and will disclose any significant findings.
More about ExaWizards Inc.
ExaWizards Inc. is an AI development company that focuses on creating AI-powered solutions in various industries. Its subsidiary, ExaMD Inc., specializes in AI services for the health and medical sectors, developing AI-powered medical devices and healthcare services.
YTD Price Performance: -26.89%
Average Trading Volume: 1,454,603
Technical Sentiment Signal: Buy
Current Market Cap: Yen26.6B
Learn more about 4259 stock on TipRanks’ Stock Analysis page.